Cambridge, MA, United States of America

Verve Therapeutics, Inc.


USPTO Granted Patents = 10

Forward Citations = 4

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Kallanthottathil G Rajeev (10 out of 199 patents)

silverMedal Caroline Reiss (6 out of 6 patents)

bronzeMedal Souvik Biswas (5 out of 6 patents)

4.  Alexandra Chadwick (5 out of 5 patents)

5.  Padma Malyala (3 out of 4 patents)

6.  Lisa N Kasiewicz (3 out of 3 patents)

7.  Christopher Cheng (3 out of 3 patents)

8.  Ellen Rohde (2 out of 2 patents)


10 patents:

Company Overview
Verve Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies for cardiovascular diseases. The company specializes in gene editing technologies aimed at permanently reducing the risk of heart disease by targeting specific genetic factors. Verve's research leverages advanced techniques to create transformative treatments that address the underlying causes of cardiovascular conditions, positioning it at the forefront of precision medicine in the field of cardiovascular health.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#231 in Cambridge, MA

#1,770 in Massachusetts

#29,839 in US

#55,986 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 4

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verve Therapeutics, Inc.. Retrieved from https://idiyas.com/company/verve-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…